Amgen (AMGN) and AstraZeneca (AZN) announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE ...
Lexington-based nonprofit hosts an array of outings for people with disabilities ...
Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) significantly reduced nasal polyp severity, the need for subsequent surgery, and ...
MedPage Today on MSN3d
Tezspire Treats Chronic Sinus Symptoms With Nasal PolypsTezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...
The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...
Waypoint Adventure has received the largest grant in its history from Dogwood Health Trust, according to a Jan. 22 news release. Dogwood Health Trust granted Waypoint Adventure $271,500.
Waypoint REIT is an internally managed Australian real estate investment trust. It owns a portfolio of about 400 service station properties, mainly leased to ASX-listed Viva Energy. About 80% of ...
Waypoint REIT Ltd (ASX:WPR) reports strong portfolio growth and strategic asset sales, despite facing profit declines due to rising interest costs.
The lesson was part of an outing planned by Waypoint Adventure. Dan Minnich cofounded the Lexington-based nonprofit in 2010.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback